These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29679339)

  • 1. Long non-coding RNA (lncRNA) MAGI2-AS3 inhibits breast cancer cell growth by targeting the Fas/FasL signalling pathway.
    Yang Y; Yang H; Xu M; Zhang H; Sun M; Mu P; Dong T; Du S; Liu K
    Hum Cell; 2018 Jul; 31(3):232-241. PubMed ID: 29679339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MAGI2-AS3 is down-regulated in intervertebral disc degeneration and participates in the regulation of FasL expression in nucleus pulposus cells.
    Cui S; Liu Z; Tang B; Wang Z; Li B
    BMC Musculoskelet Disord; 2020 Mar; 21(1):149. PubMed ID: 32143617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway.
    Yin Z; Ma T; Yan J; Shi N; Zhang C; Lu X; Hou B; Jian Z
    J Cell Physiol; 2019 Aug; 234(10):18825-18836. PubMed ID: 30924168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA MAGI2-AS3 inhibits breast cancer cell migration and invasion via sponging microRNA-374a.
    Du S; Hu W; Zhao Y; Zhou H; Wen W; Xu M; Zhao P; Liu K
    Cancer Biomark; 2019; 24(3):269-277. PubMed ID: 30883342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAGI2-AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2.
    Xu X; Yuan X; Ni J; Guo J; Gao Y; Yin W; Li F; Wei L; Zhang J
    J Cell Physiol; 2021 Feb; 236(2):1116-1130. PubMed ID: 32730644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance.
    Chen XD; Zhu MX; Wang SJ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3455-3460. PubMed ID: 31081100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
    Hao XZ; Yang K
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells.
    Zhang Z; Yi Y; Wang Z; Zhang H; Zhao Y; He R; Luo Y; Cui Z
    Mol Biotechnol; 2024 Jun; 66(6):1409-1423. PubMed ID: 37358745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA MAGI2-AS3 regulates CCDC19 expression by sponging miR-15b-5p and suppresses bladder cancer progression.
    Wang F; Zu Y; Zhu S; Yang Y; Huang W; Xie H; Li G
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):231-235. PubMed ID: 30442369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAGI2-AS3 rs7783388 polymorphism contributes to colorectal cancer risk through altering the binding affinity of the transcription factor GR to the MAGI2-AS3 promoter.
    Yang X; Wu S; Li X; Yin Y; Chen R
    J Clin Lab Anal; 2020 Oct; 34(10):e23431. PubMed ID: 32533587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6.
    Wang J; Yang C; Cao H; Yang J; Meng W; Yu M; Yu L; Wang B
    Cell Transplant; 2023; 32():9636897231154574. PubMed ID: 36852700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis.
    Ren H; Li Z; Tang Z; Li J; Lang X
    J Cell Physiol; 2020 May; 235(5):4824-4833. PubMed ID: 31709544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axis.
    Yang G; Li T; Liu J; Quan Z; Liu M; Guo Y; Wu Y; Ou L; Wu X; Zheng Y
    Genomics; 2023 Mar; 115(2):110599. PubMed ID: 36889366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MAGI2-AS3 promotes fracture healing through downregulation of miR-223-3p.
    Dong Z; Hu B; Wang S; Wang M; Sun S; Liu X; Li D; Wu D
    J Orthop Surg Res; 2024 Jun; 19(1):370. PubMed ID: 38907263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel insights for lncRNA MAGI2-AS3 in solid tumors.
    Xue C; Li G; Lu J; Luo J; Jia J
    Biomed Pharmacother; 2021 May; 137():111429. PubMed ID: 33761624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA MAGI2-AS3/miR-218-5p/GDPD5/SEC61A1 axis drives cellular proliferation and migration and confers cisplatin resistance in nasopharyngeal carcinoma.
    Cao C; Zhou S; Hu J
    Int Forum Allergy Rhinol; 2020 Aug; 10(8):1012-1023. PubMed ID: 32450008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MAGI2-AS3 inhibites tumor progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma.
    Yang R; Chen Z; Ao S; Liang L; Chen Z; Duan X; Zeng G; Deng T
    Cell Signal; 2024 Jan; 113():110954. PubMed ID: 38084836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA
    Li F; Hu Q; Pang Z; Xu X
    Cancer Biother Radiopharm; 2020 Feb; 35(1):72-76. PubMed ID: 31910343
    [No Abstract]   [Full Text] [Related]  

  • 19. Roles of lncRNA MAGI2-AS3 in human cancers.
    Kai-Xin L; Cheng C; Rui L; Zheng-Wei S; Wen-Wen T; Peng X
    Biomed Pharmacother; 2021 Sep; 141():111812. PubMed ID: 34126355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA MAGI2-AS3 Inhibits Prostate Cancer Progression by Targeting the miR-142-3p.
    Hu R; Wu P; Liu J
    Horm Metab Res; 2022 Nov; 54(11):754-759. PubMed ID: 35944561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.